Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.54 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | MMP1 | P03956 | 1/20 | 0.52 |
| ▸ | MMP2 | P08253 | 1/20 | 0.52 |
| ▸ | MMP9 | P14780 | 1/20 | 0.52 |
| ▸ | MMP8 | P22894 | 1/20 | 0.52 |
| ▸ | MMP13 | P45452 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.52 |
| ▸ | F13A1 | P00488 | 1/20 | 0.47 |
| ▸ | TGM1 | P22735 | 1/20 | 0.47 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | F2 | P00734 | 1/20 | 0.46 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.46 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10240183 | 0.92 | KMT2A (0.60) | KMT2AMEN1ALDH1A1CYP19A1CA1 | |
| SCHEMBL18327176 | 0.88 | KMT2A (0.59) | KMT2AMEN1ALDH1A1CYP19A1CA1 | |
| SCHEMBL31284709 | 0.87 | KMT2A (0.68) | KMT2AMEN1ALDH1A1CYP19A1CA1 | |
| SCHEMBL27006685 | 0.87 | KMT2A (0.68) | KMT2AMEN1ALDH1A1CYP19A1CA1 | |
| SCHEMBL29571128 | 0.87 | KMT2A (0.68) | KMT2AMEN1ALDH1A1CYP19A1CA1 | |
| SCHEMBL3540913 | 0.86 | KMT2A (0.66) | KMT2AMEN1ALDH1A1CYP19A1CA1 | |
| SCHEMBL30649118 | 0.84 | KMT2A (0.71) | KMT2AMEN1ALDH1A1CYP19A1CA1 | |
| SCHEMBL4389696 | 0.84 | KMT2A (0.71) | KMT2AMEN1ALDH1A1CYP19A1CA1 | |
| SCHEMBL12720636 | 0.83 | KMT2A (0.63) | KMT2AMEN1ALDH1A1CYP19A1CA1 | |
| SCHEMBL357662 | 0.83 | CYP19A1 (0.59) | KMT2AMEN1ALDH1A1CYP19A1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220071971-A1 | MACROCYCLIC COMPOUNDS AND THEIR USE IN THE TREATMENT OF DISEASE | NOVARTIS AG (CH) | 2022-03-10 | — | — | US | disclosed |
| CN-113227087-A | Macrocyclic compounds and their use in the treatment of disease | 诺华股份有限公司 | 2021-08-06 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220071971-A1 | MACROCYCLIC COMPOUNDS AND THEIR USE IN THE TREATMENT OF DISEASE | CFTR, PKD1, PKD2 | KMT2A 4344/4885MEN1 1226/4885ALDH1A1 1333/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.